Glycan microarrays: Powerful tools for biomarker discovery

Cancer Biomarkers

Volumn 14, Issue 1, 2014, Pages 29-41

  Muthana, Saddam M ^a   Gildersleeve, Jeffrey C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

antibodies; biomarker; Carbohydrate; glycan microarray; glycomics

Indexed keywords

BIOLOGICAL MARKER; GLYCAN BINDING PROTEIN; PROTEIN; UNCLASSIFIED DRUG; POLYSACCHARIDE;

ANTHRAX; ARTICLE; BREAST CANCER; CARCINOMA; COLORECTAL CANCER; CROHN DISEASE; HERPES SIMPLEX; HODGKIN DISEASE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFLUENZA; LYME DISEASE; MELIOIDOSIS; MESOTHELIOMA; MICROARRAY ANALYSIS; MULTIPLE SCLEROSIS; OVARY CANCER; PATIENT MONITORING; PRIORITY JOURNAL; PROSTATE CANCER; SALMONELLOSIS; SYSTEMIC SCLEROSIS; TRICHINOSIS; TULAREMIA; ANIMAL; GLYCOBIOLOGY; METABOLISM; PROCEDURES;

ANIMALS; BIOLOGICAL MARKERS; GLYCOMICS; HUMANS; MICROARRAY ANALYSIS; POLYSACCHARIDES;

EID: 84901833162     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-130383     Document Type: Article

References (88)

1. K.M. Koeller, C.H. Wong, Emerging themes in medicinal glycoscience. Nature biotechnology 18 (2000), 835-841.
2. D.H. Dube, C.R. Bertozzi, Glycans in cancer and inflamm ation-potential for therapeutics and diagnostics. Nature reviews. Drug discovery 4 (2005), 477-488.
3. A. Varki, M.E. Etzler, R.D. Cummings, J.D. Esko, Discovery and classification of glycan-binding proteins, in: A. Varki, R.D. Cummings, J.D. Esko, H.H. Freeze, P. Stanley, C.R. Bertozzi, G.W. Hart, M.E. Etzler, (Eds.), Essentials of Glycobiology, Cold Spring Harbor (NY), 2009.
4. Y. Shinohara, F. Kim, M. Shimizu, M. Goto, M. Tosu, Y. Hasegawa, Kinetic measurement of the interaction between an oligosaccharide and lectins by a biosensor based on surface plasmon resonance. European journal of biochemistry/FEBS 223 (1994), 189-194.
5. T.K. Dam, C.F. Brewer, Multivalent protein-carbohydrate interactions: isothermal titration microcalorimetry studies. Methods in enzymology 379 (2004), 107-128.
6. J. Hirabayashi, T. Hashidate, Y. Arata, N. Nishi, T. Nakamura, M. Hirashima, T. Urashima, T. Oka, M. Futai, W.E. Muller, F. Yagi, K. Kasai, Oligosaccharide specificity of galectins: A search by frontal affinity chromatography. Biochim Biophys Acta 1572 (2002), 232-254.
7. O. Oyelaran, J.C. Gildersleeve, Glycan arrays: Recent advances and future challenges. Current Opinion in Chemical Biology 13 (2009), 406-413.
8. J.L. de Paz, P.H. Seeberger, Recent advances and future challenges in glycan microarray technology. Methods Mol Biol 808 (2012), 1-12.
9. C.D. Rillahan, J.C. Paulson, Glycan microarrays for decoding the glycome. Annual Review of Biochemistry 80 (2011), 797-823.
10. E. Lonardi, C.I. Balog, A.M. Deelder, M. Wuhrer, Natural glycan microarrays. Expert Review of Proteomics 7 (2010), 761-774.
11. S. Park, J.C. Gildersleeve, O. Blixt, I. Shin, Carbohydrate microarrays. Chem Soc Rev 42 (2013), 4310-4326.
12. N. Dotan, R.T. Altstock, M. Schwarz, A. Dukler, Anti-glycan antibodies as biomarkers for diagnosis and prognosis. Lupus 15 (2006), 442-450.
13. O. Oyelaran, L.M. McShane, L. Dodd, J.C. Gildersleeve, Profiling human serum antibodies with a carbohydrate antigen microarray. Journal of Proteome Research 8 (2009), 4301-4310.
14. M.E. Huflejt, M. Vuskovic, D. Vasiliu, H. Xu, P. Obukhova, N. Shilova, A. Tuzikov, O. Galanina, B. Arun, K. Lu, N. Bovin, Anti-carbohydrate antibodies of normal sera: Findings, surprises and challenges. Molecular Immunology 46 (2009), 3037-3049.
15. N. Bovin, P. Obukhova, N. Shilova, E. Rapoport, I. Popova, M. Navakouski, C. Unverzagt, M. Vuskovic, M. Huflejt, Repertoire of human natural anti-glycan immunoglobulins. Do we have auto-antibodies? Biochim Biophys Acta (2012).
16. U. Galili, The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy. Immunology and Cell Biology 83 (2005), 674-686.
17. W.W. Young, Jr., S.I. Hakomori, P. Levine, Characterization of anti-Forssman (anti-Fs) antibodies in human sera: Their specificity and possible changes in patients with cancer. J Immunol 123 (1979), 92-96.
18. E. Miyoshi, K. Moriwaki, T. Nakagawa, Biological function of fucosylation in cancer biology. J Biochem 143 (2008), 725-729.
19. J. Burchell, R. Poulsom, A. Hanby, C. Whitehouse, L. Cooper, H. Clausen, D. Miles, J. Taylor-Papadimitriou, An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas. Glycobiology 9 (1999), 1307-1311.
20. R. Sewell, M. Backstrom, M. Dalziel, S. Gschmeissner, H. Karlsson, T. Noll, J. Gatgens, H. Clausen, G.C. Hansson, J. Burchell, J. Taylor- Papadimitriou, The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer. J Biol Chem 281 (2006), 3586-3594.
21. M. Chiricolo, N. Malagolini, S. Bonfiglioli, F. Dall'Olio, Phenotypic changes induced by expression of beta-galactoside alpha2,6 sialyltransferase I in the human colon cancer cell line SW948. Glycobiology 16 (2006), 146-154.
22. M. Granovsky, J. Fata, J. Pawling, W.J. Muller, R. Khokha, J.W. Dennis, Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat Med 6 (2000), 306-312.
23. I. Brockhausen, Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta 1473 (1999), 67-95.
24. C.Y. Huang, D.A. Thayer, A.Y. Chang, M.D. Best, J. Hoffmann, S. Head, C.H. Wong, Carbohydrate microarray for profiling the antibodies interacting with Globo H tumor antigen. Proc Natl Acad Sci U S A 103 (2006), 15-20.
25. C.C. Wang, Y.L. Huang, C.T. Ren, C.W. Lin, J.T. Hung, J.C. Yu, A.L. Yu, C.Y. Wu, C.H. Wong, Glycan microarray of Globo H and related structures for quantitative analysis of breast cancer. Proc Natl Acad Sci U S A 105 (2008), 11661-11666.
26. H.H. Wandall, O. Blixt, M.A. Tarp, J.W. Pedersen, E.P. Bennett, U. Mandel, G. Ragupathi, P.O. Livingston, M.A. Hollingsworth, J. Taylor-Papadimitriou, J. Burchell, H. Clausen, Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes. Cancer Research 70 (2010), 1306-1313.
27. J.W. Pedersen, O. Blixt, E.P. Bennett, M.A. Tarp, I. Dar, U. Mandel, S.S. Poulsen, A.E. Pedersen, S. Rasmussen, P. Jess, H. Clausen, H.H. Wandall, Seromic profiling of colorectal cancer patients with novel glycopeptide microarray. Int J Cancer 128 (2011), 1860-1871.
28. O. Blixt, D. Bueti, B. Burford, D. Allen, S. Julien, M. Hollingsworth, A. Gammerman, I. Fentiman, J. Taylor-Papadimitriou, J.M. Burchell, Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis. Breast Cancer Research: BCR 13 (2011), R25.
29. B. Burford, A. Gentry-Maharaj, R. Graham, D. Allen, J.W. Pedersen, A.S. Nudelman, O. Blixt, E.O. Fourkala, D. Bueti, A. Dawnay, J. Ford, R. Desai, L. David, P. Trinder, B. Acres, T. Schwientek, A. Gammerman, C.A. Reis, L. Silva, H. Osorio, R. Hallett, H.H. Wandall, U. Mandel, M.A. Hollingsworth, I. Jacobs, I. Fentiman, H. Clausen, J. Taylor-Papadimitriou, U. Menon, J.M. Burchell, Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer. Br J Cancer 108 (2013), 2045-2055.
30. F. Jacob, D.R. Goldstein, N.V. Bovin, T. Pochechueva, M. Spengler, R. Caduff, D. Fink, M.I. Vuskovic, M.E. Huflejt, V. Heinzelmann-Schwarz, Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array. Int J Cancer 130 (2012), 138-146.
31. M.I. Vuskovic, H. Xu, N.V. Bovin, H.I. Pass, M.E. Huflejt, Processing and analysis of serum antibody binding signals from Printed Glycan Arrays for diagnostic and prognostic applications. International Journal of Bioinformatics Research and Applications 7 (2011), 402-426.
32. C.A. Perez, M.H. Ravindranath, D. Soh, A. Gonzales, W. Ye, D.L. Morton, Serum anti-ganglioside IgM antibodies in soft tissue sarcoma: Clinical prognostic implications. Cancer Journal 8 (2002), 384-394.
33. C.H. Lawrie, T. Marafioti, C.S. Hatton, S. Dirnhofer, G. Roncador, P. Went, A. Tzankov, S.A. Pileri, K. Pulford, A.H. Banham, Cancer-associated carbohydrate identification in Hodgkin's lymphoma by carbohydrate array profiling. Int J Cancer 118 (2006), 3161-3166.
34. G.F. Springer, Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy. Journal of Molecular Medicine 75 (1997), 594-602.
35. P.R. Desai, Immunoreactive T and Tn antigens in malignancy: Role in carcinoma diagnosis, prognosis, and immunotherapy. Transfusion Medicine Reviews 14 (2000), 312-325.
36. G.F. Springer, P.R. Desai, B.D. Spencer, H. Tegtmeyer, S.C. Carlstedt, E.F. Scanlon, T/Tn antigen vaccine is effective and safe in preventing recurrence of advanced breast carcinoma. Cancer Detection and Prevention 19 (1995), 374-380.
37. S.F. Slovin, G. Ragupathi, C. Musselli, K. Olkiewicz, D. Verbel, S.D. Kuduk, J.B. Schwarz, D. Sames, S. Danishefsky, P.O. Livingston, H.I. Scher, Fully synthetic carbohydratebased vaccines in biochemically relapsed prostate cancer: Clinical trial results with alpha-N-acetylgalactosamine-Oserine/ threonine conjugate vaccine. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 21 (2003), 4292-4298.
38. S.F. Slovin, G. Ragupathi, C. Fernandez, M. Diani, M.P. Jefferson, A. Wilton, W.K. Kelly, M. Morris, D. Solit, H. Clausen, P. Livingston, H.I. Scher, A polyvalent vaccine for high-risk prostate patients: "are more antigens better?". Cancer Immunology, Immunotherapy: CII 56 (2007), 1921-1930.
39. D. Wang, N-glycan cryptic Antigens as active immunological targets in prostate cancer patients. Journal of Proteomics & Bioinformatics 5 (2012), 90-95.
40. M.L. de Leoz, H.J. An, S. Kronewitter, J. Kim, S. Beecroft, R. Vinall, S. Miyamoto, R. de Vere White, K.S. Lam, C. Lebrilla, Glycomic approach for potential biomarkers on prostate cancer: Profiling of N-linked glycans in human sera and pRNS cell lines. Disease markers 25 (2008), 243-258.
41. M.L. de Leoz, L.J. Young, H.J. An, S.R. Kronewitter, J. Kim, S. Miyamoto, A.D. Borowsky, H.K. Chew, C.B. Lebrilla, High-mannose glycans are elevated during breast cancer progression. Molecular & Cellular Proteomics: MCP 10 (2011), M110 002717.
42. Y.N. Malykh, R. Schauer, L. Shaw, N-Glycolylneuraminic acid in human tumours. Biochimie 83 (2001), 623-634.
43. P. Tangvoranuntakul, P. Gagneux, S. Diaz, M. Bardor, N. Varki, A. Varki, E. Muchmore, Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid. Proc Natl Acad Sci U S A 100 (2003), 12045-12050.
44. V. Padler-Karavani, N. Hurtado-Ziola, M. Pu, H. Yu, S. Huang, S. Muthana, H.A. Chokhawala, H. Cao, P. Secrest, D. Friedmann-Morvinski, O. Singer, D. Ghaderi, I.M. Verma, Y.T. Liu, K. Messer, X. Chen, A. Varki, R. Schwab, Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer. Cancer Research 71 (2011), 3352-3363.
45. C. Aranzamendi, B. Tefsen, M. Jansen, L. Chiumiento, F. Bruschi, T. Kortbeek, D.F. Smith, R.D. Cummings, E. Pinelli, I. Van Die, Glycan microarray profiling of parasite infection sera identifies the LDNF glycan as a potential antigen for serodiagnosis of trichinellosis. Experimental Parasitology 129 (2011), 221-226.
46. F. Kamena, M. Tamborrini, X. Liu, Y.U. Kwon, F. Thompson, G. Pluschke, P.H. Seeberger, Synthetic GPI array to study antitoxic malaria response. Nature Chemical Biology 4 (2008), 238-240.
47. J. Heimburg-Molinaro, J.W. Priest, D. Live, G.J. Boons, X. Song, R.D. Cummings, J.R. Mead, Microarray analysis of the human antibody response to synthetic Cryptosporidium glycopeptides. Int J Parasitol 43 (2013), 901-907.
48. E. Clo, S.K. Kracun, A.S. Nudelman, K.J. Jensen, J.A. Liljeqvist, S. Olofsson, T. Bergstrom, O. Blixt, Characterization of the viral o-glycopeptidome: A novel tool of relevance for vaccine design and serodiagnosis. J Virol 86 (2012), 6268-6278.
49. J. Stevens, O. Blixt, J.C. Paulson, I.A. Wilson, Glycan mi croarray technologies: Tools to survey host specificity of influenza viruses. Nature reviews. Microbiology 4 (2006), 857-864.
50. J. Stevens, O. Blixt, L. Glaser, J.K. Taubenberger, P. Palese, J.C. Paulson, I.A. Wilson, Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. Journal of Molecular Biology 355 (2006), 1143-1155.
51. J. Stevens, O. Blixt, L.M. Chen, R.O. Donis, J.C. Paulson, I.A. Wilson, Recent avian H5N1 viruses exhibit increased propensity for acquiring human receptor specificity. Journal of Molecular Biology 381 (2008), 1382-1394.
52. T.R. Maines, A. Jayaraman, J.A. Belser, D.A. Wadford, C. Pappas, H. Zeng, K.M. Gustin, M.B. Pearce, K. Viswanathan, Z.H. Shriver, R. Raman, N.J. Cox, R. Sasisekharan, J.M. Katz, T.M. Tumpey, Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 325 (2009), 484-487.
53. X. Song, H. Yu, X. Chen, Y. Lasanajak, M.M. Tappert, G.M. Air, V.K. Tiwari, H. Cao, H.A. Chokhawala, H. Zheng, R.D. Cummings, D.F. Smith, A sialylated glycan microarray reveals novel interactions of modified sialic acids with proteins and viruses. J Biol Chem 286 (2011), 31610-31622.
54. D. Wang, S. Liu, B.J. Trummer, C. Deng, A. Wang, Carbohydrate microarrays for the recognition of cross-reactive molecular markers of microbes and host cells. Nature Biotechnology 20 (2002), 275-281.
55. N. Parthasarathy, D. DeShazer, M. England, D.M. Waag, Polysaccharide microarray technology for the detection of Burkholderia pseudomallei and Burkholderia mallei antibodies. Diagnostic Microbiology and Infectious Disease 56 (2006), 329-332.
56. N. Parthasarathy, R. Saksena, P. Kovac, D. Deshazer, S.J. Peacock, V. Wuthiekanun, H.S. Heine, A.M. Friedlander, C.K. Cote, S.L. Welkos, J.J. Adamovicz, S. Bavari, D.M. Waag, Application of carbohydrate microarray technology for the detection of Burkholderia pseudomallei, Bacillus anthracis and Francisella tularensis antibodies. Carbohydr Res 343 (2008), 2783-2788.
57. N.R. Thirumalapura, R.J. Morton, A. Ramachandran, J.R. Malayer, Lipopolysaccharide microarrays for the detection of antibodies. Journal of Immunological Methods 298 (2005), 73-81.
58. O. Blixt, J. Hoffmann, S. Svenson, T. Norberg, Pathogen specific carbohydrate antigen microarrays: A chip for detection of Salmonella O-antigen specific antibodies. Glycoconj J 25 (2008), 27-36.
59. M.D. Disney, P.H. Seeberger, The use of carbohydrate microarrays to study carbohydrate-cell interactions and to detect pathogens. Chemistry & Biology 11 (2004), 1701-1707.
60. X. Song, Y. Lasanajak, B. Xia, J. Heimburg-Molinaro, J.M. Rhea, H. Ju, C. Zhao, R.J. Molinaro, R.D. Cummings, D.F. Smith, Shotgun glycomics: A microarray strategy for functional glycomics. Nature Methods 8 (2011), 85-90.
61. G.S. Firestein, Evolving concepts of rheumatoid arthritis. Nature 423 (2003), 356-361.
62. W. Hueber, W.H. Robinson, Proteomic biomarkers for autoimmune disease. Proteomics 6 (2006), 4100-4105.
63. I. Dotan, S. Fishman, Y. Dgani, M. Schwartz, A. Karban, A. Lerner, O. Weishauss, L. Spector, A. Shtevi, R.T. Altstock, N. Dotan, Z. Halpern, Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. Gastroenterology 131 (2006), 366-378.
64. B.D. Trapp, J. Peterson, R.M. Ransohoff, R. Rudick, S. Mork, L. Bo, Axonal transection in the lesions of multiple sclerosis. The New England Journal of Medicine 338 (1998), 278-285.
65. H. Lassmann, W. Bruck, C. Lucchinetti, Heterogeneity of multiple sclerosis pathogenesis: Implications for diagnosis and therapy. Trends in Molecular Medicine 7 (2001), 115-121.
66. M. Schwarz, L. Spector, M. Gortler, O. Weisshaus, L. Glass-Marmor, A. Karni, N. Dotan, A. Miller, Serum anti-Glc(alpha1,4)Glc(alpha) antibodies as a biomarker for relapsing-remitting multiple sclerosis. Journal of the Neurological Sciences 244 (2006), 59-68.
67. J. Brettschneider, T.D. Jaskowski, H. Tumani, S. Abdul, D. Husebye, H. Seraj, H.R. Hill, E. Fire, L. Spector, J. Yarden, N. Dotan, J.W. Rose, Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases. Journal of Neuroimmunology 217 (2009), 95-101.
68. S.M. Muthana, C.T. Campbell, J.C. Gildersleeve, Modifications of glycans: Biological significance and therapeutic opportunities. ACS Chem Biol 7 (2012), 31-43.
69. T. Grader-Beck, F. Boin, S. von Gunten, D. Smith, A. Rosen, B.S. Bochner, Antibodies recognising sulfated carbohydrates are prevalent in systemic sclerosis and associated with pulmonary vascular disease. Annals of the Rheumatic Diseases 70 (2011), 2218-2224.
70. O. Blixt, E. Clo, A.S. Nudelman, K.K. Sorensen, T. Clausen, H.H. Wandall, P.O. Livingston, H. Clausen, K.J. Jensen, A high-throughput O-glycopeptide discovery platform for seromic profiling. Journal of Proteome Research 9 (2010), 5250-5261.
71. Y. Zhang, C. Campbell, Q. Li, J.C. Gildersleeve, Multidimensional glycan arrays for enhanced antibody profiling. Molecular Bio Systems 6 (2010), 1583-1591.
72. J.L. Gulley, P.M. Arlen, R.A. Madan, K.Y. Tsang, M.P. Pazdur, L. Skarupa, J.L. Jones, D.J. Poole, J.P. Higgins, J.W. Hodge, V. Cereda, M. Vergati, S.M. Steinberg, S. Halabi, E. Jones, C. Chen, H. Parnes, J.J. Wright, W.L. Dahut, J. Schlom, Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer. Cancer Immunology, Immunotherapy: CII 59 (2010), 663-674.
73. R.J. Lechleider, P.M. Arlen, K.Y. Tsang, S.M. Steinberg, J. Yokokawa, V. Cereda, K. Camphausen, J. Schlom, W.L. Dahut, J.L. Gulley, Safety and immunologic response of a viral vaccine to prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an adjuvant. Clin Cancer Res 14 (2008), 5284-5291.
74. R.A. Madan, J.L. Gulley, J. Schlom, S.M. Steinberg, D.J. Liewehr, W.L. Dahut, P.M. Arlen, Analysis of overall survival in patients with nonmetastatic castration-resistant prostate cancer treated with vaccine, nilutamide, and combination therapy. Clin Cancer Res 14 (2008), 4526-4531.
75. C.T. Campbell, J.L. Gulley, O. Oyelaran, J.W. Hodge, J. Schlom, J.C. Gildersleeve, Serum antibodies to blood group A predict survival on PROSTVAC-VF. Clin Cancer Res 19 (2013), 1290-1299.
76. D. Wang, G.T. Carroll, N.J. Turro, J.T. Koberstein, P. Kovac, R. Saksena, R. Adamo, L.A. Herzenberg, L. Steinman, Photogenerated glycan arrays identify immunogenic sugar moieties of Bacillus anthracis exosporium. Proteomics 7 (2007), 180-184.
77. D. Wang, J. Lu, Glycan arrays lead to the discovery of autoim munogenic activity of SARS-CoV. Physiological Genomics 18 (2004), 245-248.
78. M.A. Oberli, M.L. Hecht, P. Bindschadler, A. Adibekian, T. Adam, P.H. Seeberger, A possible oligosaccharide-conjugate vaccine candidate for Clostridium difficile is antigenic and immunogenic. Chemistry & Biology 18 (2011), 580-588.
79. S. Olofsson, J.E. Hansen, Host cell glycosylation of viral glycoproteins-a battlefield for host defence and viral resistance. Scandinavian Journal of Infectious Diseases 30 (1998), 435-440.
80. A. Trkola, M. Purtscher, T. Muster, C. Ballaun, A. Buchacher, N. Sullivan, K. Srinivasan, J. Sodroski, J.P. Moore, H. Katinger, Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J Virol 70 (1996), 1100-1108.
81. J.R. Mascola, G. Stiegler, T.C. Van Cott, H. Katinger, C.B. Carpenter, C.E. Hanson, H. Beary, D. Hayes, S.S. Frankel, D.L. Birx, M.G. Lewis, Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med 6 (2000), 207-210.
82. E.W. Adams, D.M. Ratner, H.R. Bokesch, J.B. McMahon, B.R. O'Keefe, P.H. Seeberger, Oligosaccharide and glycoprotein microarrays as tools in HIV glycobiology; glycandependent gp120/protein interactions. Chemistry & Biology 11 (2004), 875-881.
83. R.J. Luallen, J. Lin, H. Fu, K.K. Cai, C. Agrawal, I. Mboudjeka, F.H. Lee, D. Montefiori, D.F. Smith, R.W. Doms, Y. Geng, An engineered Saccharomyces cerevisiae strain binds the broadly neutralizing human immunodeficiency virus type 1 antibody 2G12 and elicits mannose-specific gp120-binding antibodies. J Virol 82 (2008), 6447-6457.
84. D.C. Dunlop, C. Bonomelli, F. Mansab, S. Vasiljevic, K.J. Doores, M.R. Wormald, A.S. Palma, T. Feizi, D.J. Harvey, R.A. Dwek, M. Crispin, C.N. Scanlan, Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans. Glycobiology 20 (2010), 812-823.
85. C.T. Campbell, S.R. Llewellyn, T. Damberg, I.L. Morgan, M. Robert-Guroff, J.C. Gildersleeve, High-Throughput Profiling of Anti-Glycan Humoral Responses to SIV Vaccination and Challenge. PLoS One 8 (2013), e75302.
86. H. Auchincloss, Jr., D.H. Sachs, Xenogeneic transplantation. Annual Review of Immunology 16 (1998), 433-470.
87. O. Blixt, M. Kumagai-Braesch, A. Tibell, C.G. Groth, J. Holgersson, Anticarbohydrate Antibody Repertoires in Patients Transplanted with Fetal Pig Islets Revealed by Glycan Arrays. American Journal of Transplantation 9 (2009), 83-90.
88. O. Oyelaran, Q. Li, D. Farnsworth, J.C. Gildersleeve, Microarrays with varying carbohydrate density reveal distinct subpopulations of serum antibodies. Journal of Proteome Research 8 (2009), 3529-3538.